Kronos Bio, Inc. (KRON)

Last Closing Price: 0.73 (2025-05-08)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Kronos Bio, Inc. (KRON) had Net Income of $-25.81M for the most recently reported fiscal quarter, ending 2024-12-31.

Figures for fiscal quarter ending 2024-12-31
Income Statement Financials
$2.27M
Net Income
$-25.81M
--
$2.27M
$29.42M
$-27.15M
$1.34M
$-25.81M
$-25.81M
$-25.81M
$-25.81M
$-25.81M
$-25.81M
$-27.15M
$-27.12M
60.07M
60.07M
$-0.43
$-0.43
Balance Sheet Financials
$115.23M
$3.82M
$9.13M
$124.36M
$15.28M
--
$21.51M
$36.78M
$87.58M
$87.58M
$87.58M
60.46M
Cash Flow Statement Financials
$-65.44M
$85.44M
$0.24M
$66.35M
$86.60M
$20.25M
$9.22M
--
--
Fundamental Metrics & Ratios
7.54
--
--
--
--
100.00%
-1196.21%
-1196.21%
--
-1137.14%
-1137.14%
$-65.44M
--
--
--
0.02
--
--
--
-29.47%
-29.47%
-20.76%
-29.47%
$1.45
$-1.09
$-1.09